1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - France

Healthcare Analysis & Statistics 2022 - France

1-30 of 76 reports

Weight Loss/Weight Management (Obesity) - Epidemiology Forecast - 2032

  • $ 4750
  • September 2022
  • 160 pages

"Obesity - Epidemiology Forecast-2032" report delivers an in-depth understanding of the obesity, historical and forecasted epidemiology as well as the obesity trends in the United States, EU5 (Germany, ...

  • Spain
  • France
  • Obesity
  • Industry analysis

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 162 pages

"Cholangiocarcinoma (CCA)- Epidemiology Forecast-2032" report delivers an in-depth understanding of the Cholangiocarcinoma, historical and forecasted epidemiology as well as the Cholangiocarcinoma trends ...

  • Japan
  • United States
  • Epidemiology
  • Industry analysis

Head and Neck cancer (HNC) - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 116 pages

‘Head and Neck Cancer (HNC)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of HNC historical and forecasted epidemiology as well as the epidemiology trends in the United States, ...

  • United States
  • France
  • Cancer
  • Epidemiology
  • Industry analysis

Peripheral T cell Lymphoma - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 117 pages

" Peripheral T-cell Lymphoma - Epidemiology Forecast– 2032” report delivers an in-depth understanding of the PTCL, historical and forecasted epidemiology as well as the PTCL market trends in the United ...

  • Japan
  • United States
  • Lymphoma
  • Industry analysis
  • Stem Cell Transplantation
  • Health Expenditure

Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 141 pages

"Cytokine Release Syndrome (CRS)- Epidemiology Forecast-2032" report delivers an in-depth understanding of the cytokine release syndrome, historical and forecasted epidemiology as well as the cytokine ...

  • United States
  • Japan
  • Immunotherapy
  • Epidemiology
  • Industry analysis
  • Drug Approval

Alcohol Use Disorder - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 76 pages

‘Alcohol Use Disorder - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well as the Alcohol Use Disorde ...

  • United States
  • Spain
  • Addiction Disorder
  • Industry analysis
  • Alcohol Excessive Use

PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 140 pages

‘PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032’ report delivers an in-depth understanding of PCSK9i, historical and forecasted epidemiology in the 7MM, i.e., the United States, ...

  • Spain
  • France
  • Epidemiology
  • Cardiovascular Disease
  • Industry analysis

Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 160 pages

" Oncolytic Virus Therapies (OVTs) - Epidemiology Forecast-2032" report delivers an in-depth understanding of the oncolytic virus therapies, historical and forecasted epidemiology as well as OVTs trends ...

  • Spain
  • France
  • Cancer
  • Therapy
  • Industry analysis

Acute Kidney Injury (AKI) - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 77 pages

" Acute Kidney Injury - Epidemiology Forecast– 2032” report delivers an in-depth understanding of the AKI, historical and forecasted epidemiology trends in the United States, the EU-5 (Germany, Spain, ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis
  • Health Expenditure

Myelofibrosis - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 110 pages

‘Myelofibrosis - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the disease, historical and forecasted epidemiology in the United States, the EU-5 (Germany, Spain, Italy, ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • $ 4750
  • September 2022
  • 141 pages

‘Psoriatic Arthritis (PsA) – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of psoriatic arthritis (PsA) in the United States, ...

  • Spain
  • France
  • Autoimmune Disease
  • Industry analysis

BESREMi Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“BESREMi Drug Insight and Market Forecast – 2032” report provides comprehensive insights about BESREMi for Polycythemia Vera in the 7MM. A detailed picture of the BESREMi for Polycythemia Vera in ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure

BOMEDEMSTAT Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“BOMEDEMSTAT Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about BOMEDEMSTAT for Polycythemia Vera in the 7MM. A detailed picture of the BOMEDEMSTAT fo ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure

GIVINOSTAT Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“GIVINOSTAT Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about GIVINOSTAT for Polycythemia Vera in the 7MM. A detailed picture of the GIVINOSTAT for Polycythemia ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure

Itacitinib Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“Itacitinib Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Itacitinib for Polycythemia Vera in the 7MM. A detailed picture of the Itacitinib for Polycythemia ...

  • Europe
  • World
  • Blood Disease
  • Industry analysis
  • Health Expenditure

JAKAFI Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“JAKAFI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JAKAFI for Polycythemia Vera in the 7MM. A detailed picture of the JAKAFI for Polycythemia Vera in the ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure

Rusfertide Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“Rusfertide Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Rusfertide for Polycythemia Vera in the 7MM. A detailed picture of the Rusfertide for Polycythemia ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure
  • Iron Export

Sapablursen Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“Sapablursen Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Sapablursen for Polycythemia Vera in the 7MM. A detailed picture of the Sapablursen fo ...

  • Europe
  • Japan
  • Blood Disease
  • Industry analysis
  • Health Expenditure

CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CONTRAVE (Naltrexon-Bupropion) for Obesity in the 7MM. A detailed picture of ...

  • Europe
  • Japan
  • Smoking Cessation
  • Obesity
  • Industry analysis
  • Health Expenditure

IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about IMCIVREE (Setmelanotide) for Obesity in the 7MM. A detailed picture of the IMCIVREE ...

  • Europe
  • Japan
  • Obesity
  • Industry analysis
  • Health Expenditure

QSYMIA (Phentermine– topiramate), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“QSYMIA (Phentermine – topiramate), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about QSYMIA (Phentermine– topiramate) for Obesity in the 7MM. A detailed picture ...

  • Europe
  • Japan
  • Obesity
  • Weight Loss
  • Industry analysis
  • Health Expenditure
  • Food Consumption

SAXENDA (Liraglutide), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“SAXENDA (Liraglutide), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SAXENDA (Liraglutide) for Obesity in the 7MM. A detailed picture of the SAXENDA (Liraglutide) ...

  • Europe
  • Japan
  • Glucagon Like Peptide 1 Receptor Activator
  • Obesity
  • Industry analysis
  • Health Expenditure

Tirzepatide, Emerging Drug Insight and Market Forecast – 2032

  • $ 3250
  • September 2022
  • 30 pages

“Tirzepatide, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Tirzepatide for Obesity in the 7MM. A detailed picture of the Tirzepatide for Obesity ...

  • Europe
  • Japan
  • Obesity
  • Industry analysis
  • Health Expenditure

WEGOVY (Semaglutide), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“WEGOVY (Semaglutide), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about WEGOVY (Semaglutide) for Obesity in the 7MM. A detailed picture of the WEGOVY (Semaglutide) ...

  • Europe
  • Japan
  • Obesity
  • Industry analysis
  • Health Expenditure
  • Use Of Prescription Drugs

XENICAL (Orlistat), Drug Insight and Market Forecast – 2032

  • $ 2750
  • September 2022
  • 30 pages

“XENICAL (Orlistat), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XENICAL (Orlistat) for Obesity in the 7MM. A detailed picture of the XENICAL (Orlistat) ...

  • Europe
  • Japan
  • Obesity
  • Industry analysis
  • Health Expenditure

Benralizumab Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“Benralizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about benralizumab for Chronic Spontaneous Urticaria in seven major markets. A detailed picture ...

  • Japan
  • World
  • Monoclonal Antibody
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Dupilumab Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“Dupilumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Dupilumab for Chronic Spontaneous Urticaria in seven major markets. A detailed picture of ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

KPL-716 Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“KPL-716 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about KPL-716 for Chronic Spontaneous Urticaria in seven major markets. A detailed picture of the ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Ligelizumab Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“Ligelizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ligelizumab for Chronic Spontaneous Urticaria in seven major markets. A detailed picture ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

LOU064 Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“LOU064 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LOU064 for Chronic Spontaneous Urticaria in seven major markets. A detailed picture of the LOU064 ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on